5-HT2A Receptor Antagonists
| Cat. No. | Product Name / Activity |
|---|---|
| 1809 | Altanserin hydrochloride |
| 5-HT2A receptor antagonist | |
| 5584 | Aripiprazole |
| 5-HT2A antagonist; also D2 and 5-HT1A receptor partial agonist | |
| 0444 | Clozapine |
| 5-HT2A and 5-HT2C antagonist; also dopamine antagonist | |
| 4470 | EMD 281014 hydrochloride |
| Selective 5-HT2A antagonist | |
| 4958 | Eplivanserin hemifumarate |
| Potent and selective 5-HT2A antagonist | |
| 0523 | 4F 4PP oxalate |
| Selective 5-HT2A antagonist | |
| 0908 | Ketanserin tartrate |
| Selective 5-HT2A antagonist. Also antagonist at 5-HT1D | |
| 4173 | MDL 100907 |
| Potent and selective 5-HT2A antagonist | |
| 0870 | MDL 11,939 |
| 5-HT2A antagonist | |
| 1644 | Mesulergine hydrochloride |
| 5-HT2A and 5-HT2C antagonist; also D2-like partial agonist | |
| 4349 | Olanzapine |
| 5-HT2A antagonist; also D2 antagonist; atypical antipsychotic | |
| 4493 | Paliperidone |
| 5-HT2A antagonist; also D2 antagonist; atypical antipsychotic | |
| 1742 | R-96544 hydrochloride |
| Potent, selective 5-HT2A antagonist | |
| 2865 | Risperidone |
| 5-HT2A antagonist; also D2 antagonist; atypical antipsychotic | |
| 3739 | Sarpogrelate hydrochloride |
| Selective 5-HT2A antagonist | |
| 6336 | Trazodone hydrochloride |
| 5-HT2A and α1 adrenoceptor antagonist; also enhances neural differentiation; antidepressant and neuroprotectant |
Cardiovascular Research Product Guide
Our Cardiovascular Guide highlights over 250 products for cardiovascular research.
Request copyRequest PDF
5-HT Scientific Review
Our 5-HT review summarizes the serotonin receptor subtypes and highlights their importance in mediating various physiological & pharmacological processes.
Request copyRequest PDFCardiovascular Life Science Poster
Written by J.J. Maguire and A.P. Davenport
Our Cardiovascular poster highlights the key G protein-coupled receptors involved in the regulation of vascular reactivity.
Request copyDownload PDFDepression Life Science Poster
Written by P. Skolnich et al
Our Depression poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder.
Request copyDownload PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF